Sebia, a global specialty diagnostic company providing solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, has acquired Zeus Scientific, an in vitro diagnostic (IVD) company based in New Jersey, U.S., specialized in autoimmune and infectious diseases techno- logies. Financial terms of the agreement are undisclosed.

Kupando, a Berlin-based biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases, has closed its Series A funding round which raised €13 million.

Tokyo-based Showa Denko Materials and Kidswell Bio Corporation, also based in Tokyo have entered into an agreement to enable process development as well as clinical manufacturing of cell therapy products utilizing the advantage of SHED (Stem cells from Human Exfoliated Deciduous teeth) which is under development by Kidswell Bio. Under the terms of agreement, Minaris […]

Swedish medtech start-up Capitainer has entered a collaboration agreement with Timothy J. Garrett Laboratory, College of Medicine, University of Florida. Dr Tim Garrett is one of the leading experts and an authority in the US when it comes to applying mass spectrometry within the area of metabolomics and its clinical applications.